Authors | Year | Duration | Group1/Sample | Group 2/Sample | Group 3/Sample | Group 4/Sample | Group 5/Sample |
---|---|---|---|---|---|---|---|
Alvarez E et al. [10] | 2011 | 6 weeks | Vortioxetine 5 mg/108 | Vortioxetine 10 mg/100 | Venlafaxine/113 | Placebo/105 | --- |
Baldwin DS et al. [14] | 2012 | 8-week | Vortioxetine 2.5 mg/155 | Vortioxetine 5 mg/155 | Vortioxetine 10 mg/151 | Duloxetine 60 mg/149 | Placebo/145 |
Mahableshwarkar AR et al. [16] | 2013 | 8 weeks | Vortioxetine 2.5 mg/146 | Vortioxetine 5 mg/153 | Duloxetine 60 mg/149 | Placebo/149 | --- |
Katona C et al. [11] | 2012 | 8 weeks | Vortioxetine 5 mg/day/154 | Duloxetine/147 | Placebo/145 | --- | --- |
Jain R et al. [15] | 2013 | 6 wks | Vortioxetine 5 mg/300 | Placebo/300 | --- | --- | --- |
Boulenger JP et al. [12] | 2013 | 8 weeks | Vortioxetine 15 mg/151 | Vortioxetine 20 mg/151 | Duloxetine/147 | Placebo/158 | --- |
Henigsberg N et al. [13] | 2012 | 8 wks | Vortioxetine 1 mg/124 | Vortioxetine 5 mg/129 | Vortioxetine 10 mg/122 | Placebo/128 | --- |